DCPrime BV
Trending Articles
Related Content
Research & Development
DCprime and Glycotope to advance cancer vaccination and therapeutic antibody platforms
DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno-oncology company built on world-leading glycobiology expertise, have expanded their existing partnership through a new research collaboration and licensing agreement